Egypt and Sierra Leone sign MoU to boost pharmaceutical cooperation

The Egyptian Drug Authority signed a memorandum of understanding with Sierra Leone's Pharmacy Board to enhance cooperation in pharmaceutical regulation and capacity building.

The agreement was signed by Ali El Ghamrawy, Chairperson of the Egyptian Drug Authority, and James Peter Komie, Chairperson of the Pharmacy Board of Sierra Leone. It took place in the presence of Ambassador Sadiq Sillah on the sidelines of the fifth edition of Africa Health ExCon 2026.

El Ghamrawy said the deal aligns with efforts to expand partnerships across African regulatory bodies. He noted it would support regulatory integration and improve access to safe medical products.

Ambassador Sillah praised Egypt's role in sharing expertise. Komie highlighted benefits for Sierra Leone's pharmaceutical sector through training and inspections.

Relaterade artiklar

Senior Egyptian and Libyan officials discussed expanding healthcare cooperation, with a focus on pharmaceutical supply and medical industry localisation.

Rapporterad av AI

Egypt's Drug Authority Chairperson Ali El Ghamrawy met with Sweden's Ambassador to Egypt Dag Juhlin-Dannfelt to explore strengthening bilateral cooperation in the pharmaceutical sector. The meeting followed up on the recent visit by Sweden’s Minister of Health to Egypt. Both sides committed to deepening collaboration for enhanced drug security.

Egyptian Health Minister Khaled Abdel Ghaffar urged stronger local pharmaceutical manufacturing to build resilient healthcare supply chains.

Rapporterad av AI

Egypt’s health minister met the British ambassador in Cairo to explore stronger ties in medical training, digital health and hospital management.

Pharco Pharmaceuticals plans to invest around EGP 1.5bn next year, up from about EGP 1.15bn in 2025, to expand production capacity and strengthen its presence in domestic and export markets, Chairperson Sherine Helmy said. The company is prioritising improvements in product quality alongside expansion and diversification of production lines.

Denna webbplats använder cookies

Vi använder cookies för analys för att förbättra vår webbplats. Läs vår integritetspolicy för mer information.
Avböj